I think in the world of Big Pharma the expression "not-for-profit" can be interpreted as meaning "not gouging".
You can hardly expect a company re-priortising existing/taking on additional research related to Covid19 to suddenly go all-in on philanthropy.
Ann: CSL Results Announcement, page-83
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$284.95 |
Change
-0.590(0.21%) |
Mkt cap ! $137.7B | |||
| Open | High | Low | Value | Volume |
| $287.55 | $287.60 | $283.86 | $69.86M | 244.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 71 | $284.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $284.96 | 13 | 5 |
View Market Depth
| Last trade - 15.52pm 14/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |